Article Details
Retrieved on: 2019-12-13 04:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>ValuEngine upgraded shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) from a sell rating to a hold rating in a research note released on Tuesday ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here